Hero Image

About our company

We invent for a more hopeful future.

We aspire to be the premier research-intensive biopharmaceutical company in the world

For more than 125 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives.

We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.

Today, we continue to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases, such as HIV and Ebola, and emerging animal diseases.

 

Watch highlights of our discoveries and commitments from the start of our company to today.

primary article image
Responsibility

The heart of our mission

We believe corporate responsibility is about our health, social, environmental and economic impact on people and communities around the world.

Leadership

The team that guides our work

Our leaders focus on our mission to save and improve lives around the world. This is the foundation of everything we do.

Our company by the numbers

145

employees

Our culture
$9.9B

research and development investment in 2019

Our research
$2.8B

total philanthropy in 2018

Our giving

MSD in Belgium

MSD has 2 sites in Belgium: 2 are located in Brussels - Watermael-Boitsfort & Schuman. The MSD site in Grand Duchy of Luxembourg is located in Windhof.

Brussels, Watermael-Boitsfort
Brussels, Schuman
Luxembourg, Windhof

Anchored in Belgium & Luxembourg

At MSD Belgium & Luxembourg, more than 370 people work in national and international positions in various areas (as of 01/19). Belgium is one of more than 50 countries in which MSD conducts clinical research.

picto_forschung

Research and Development

picto_produktion_qa

Manufacturing, Production and Quality Assurance

picto_marketing_vertrieb

Marketing and Distribution

picto_organigramm

Human Resources, Supply Chain Management, Finance, IT

picto_support

Serve patients in more than 140 countries

picto_msd_logo

MSD

Our company has been active in Belgium since 1965 and is committed to strengthen health literacy and health economics, among other things. In 2018, MSD Belgium received the “Top Employer” and “Top Employer Europe” certifications for the third time in a row.

Culture & values

Our values are driven by a desire to improve life

We’ve built a culture that embraces scientific excellence, operates with the highest standards of integrity, expands access to our products and employs a diverse workforce that values collaboration.

History

Our past and our future

For more than 125 years, we’ve focused on not just the next quarter, but the next quarter century.

Get to know us through our stories

Learn about the heartbeat of our company.

View our stories

Meet our leaders at MSD BeLux: Rietja Hart, Finance Lead

We are continuing a series of articles in which we would like to introduce you to our leaders at MSD BeLux, to get to know what drives them in their roles, what it’s like to lead at MSD BeLux, and what it’s like being part of a company with such a significant impact on the […]

Read more

Next: Meet our leaders at MSD BeLux: Rietja Hart, Finance Lead

Katrien De Vos

Katrien De Vos appointed to Managing Director, MSD Belgium & Luxembourg

Katrien De Vos has taken the lead of MSD Belgium & Luxembourg since Monday, May 1.  In her new role of Managing Director, she takes over from An Cloet, External Affairs Director at MSD Belgium, who held the position ad interim for the past 6 months. Prior to joining MSD, Katrien De Vos held various […]

Read more

Next: Katrien De Vos appointed to Managing Director, MSD Belgium & Luxembourg

Meet our leaders at MSD BeLux: Dr. Laurent Viérin, Country Medical Director

We are starting a series of articles in which we would like to introduce you to our leaders at MSD BeLux, to get to know what drives them in their roles, what it’s like to lead at MSD BeLux, and what it’s like being part of a company with such a significant impact on the […]

Read more

Next: Meet our leaders at MSD BeLux: Dr. Laurent Viérin, Country Medical Director

Together against pneumococcal diseases

What are the numbers onhospitalisation and deaths? For adults above the age of 50, the chance at hospitalisation is lower in comparison to adults above the age of 65. Yet, pneumococcal diseases cause 5800 adults above the age of 50 to be hospitalised every year.2 As people get older, the chance of developing severe symptoms […]

Read more

Next: Together against pneumococcal diseases

Meet our leaders at MSD BeLux: Philippe Decerf, Business Operations Lead

We are starting a series of articles in which we would like to introduce you to our leaders at MSD BeLux, to get to know what drives them in their roles, what it’s like to lead at MSD BeLux, and what it’s like being part of a company with such a significant impact on the […]

Read more

Next: Meet our leaders at MSD BeLux: Philippe Decerf, Business Operations Lead

Meet our leaders at MSD BeLux: Rietja Hart, Finance Lead

We are continuing a series of articles in which we would like to introduce you to our leaders at MSD BeLux, to get to know what drives them in their roles, what it’s like to lead at MSD BeLux, and what it’s like being part of a company with such a significant impact on the […]

Read more

Next: Meet our leaders at MSD BeLux: Rietja Hart, Finance Lead

Katrien De Vos

Katrien De Vos appointed to Managing Director, MSD Belgium & Luxembourg

Katrien De Vos has taken the lead of MSD Belgium & Luxembourg since Monday, May 1.  In her new role of Managing Director, she takes over from An Cloet, External Affairs Director at MSD Belgium, who held the position ad interim for the past 6 months. Prior to joining MSD, Katrien De Vos held various […]

Read more

Next: Katrien De Vos appointed to Managing Director, MSD Belgium & Luxembourg

Meet our leaders at MSD BeLux: Dr. Laurent Viérin, Country Medical Director

We are starting a series of articles in which we would like to introduce you to our leaders at MSD BeLux, to get to know what drives them in their roles, what it’s like to lead at MSD BeLux, and what it’s like being part of a company with such a significant impact on the […]

Read more

Next: Meet our leaders at MSD BeLux: Dr. Laurent Viérin, Country Medical Director

Together against pneumococcal diseases

What are the numbers onhospitalisation and deaths? For adults above the age of 50, the chance at hospitalisation is lower in comparison to adults above the age of 65. Yet, pneumococcal diseases cause 5800 adults above the age of 50 to be hospitalised every year.2 As people get older, the chance of developing severe symptoms […]

Read more

Next: Together against pneumococcal diseases

Meet our leaders at MSD BeLux: Philippe Decerf, Business Operations Lead

We are starting a series of articles in which we would like to introduce you to our leaders at MSD BeLux, to get to know what drives them in their roles, what it’s like to lead at MSD BeLux, and what it’s like being part of a company with such a significant impact on the […]

Read more

Next: Meet our leaders at MSD BeLux: Philippe Decerf, Business Operations Lead

Previous
Next

Our areas of focus

Through innovation and scientific excellence, we deliver vaccines and medicines that may help millions of people around the world.

Oncology

Our mission is to deliver innovations that extend and improve the lives of people with cancer.

Learn about oncology

Vaccines

Vaccines are one of the greatest public health success stories – and we’ve been discovering, developing and delivering vaccines to help prevent disease for over 100 years.

Learn about vaccines

Infectious diseases

We play an important role in discovering and developing innovative medicines and vaccines to treat and prevent infectious diseases, including HIV and Ebola.

Learn about infectious diseases

COVID-19

As a company dedicated to saving and improving lives, we have a special responsibility to help in the fight against COVID-19. We’ve been fully committed to developing an effective response to the COVID-19 pandemic since it was first recognized.

Learn more about our response to COVID-19

Discovery & Development

We are pushing the boundaries in research where we can make the greatest difference, now and in the future.

Learn about our work